Skip directly to site content Skip directly to page options Skip directly to A-Z link


Centers for Disease Control and Prevention. CDC twenty four seven. Saving Lives, Protecting People
															Search

		Submit


Vaccine Safety


Section Navigation
			
			CDC Home


Facebook
        Twitter
        LinkedIn
        Syndicate





MMRV Vaccine and Febrile Seizures										Related Pages
										A study showing the risk levels for several health outcomes, including seizures, after measles, mumps, rubella, and varicella (MMRV) combination vaccine in children aged 12 to 23 months has been published in the July 2010 print issue of Pediatrics (published online June 28).
mom and baby
The study, “Measles-Mumps-Rubella-Varicella Combination Vaccine and the Risk of Febrile Seizures” uses computerized information from CDC’s Vaccine Safety Datalink (VSD) Project. VSD consists of managed care organizations which gather vaccination and demographic information, as well as health outcomes of their patients (more than 9.2 million across the U.S.)
Researchers examined VSD data on more than 83,000 children who received their first dose of MMRV vaccine and over 376,000 children who received their first doses of MMR and varicella vaccines given at the same visit from the year 2000 to the year 2008.
The Study’s Main Findings Report:
For MMRV combination vaccine, there was 1 additional febrile seizure for every 2,300 doses given, compared to separate MMR plus varicella vaccines in the 7 to 10 days following vaccination.
Of the children identified as having seizures following the 7 to 10-day vaccination period, about 90% were found to be febrile seizures.
The rate of seizures in this timeframe was 85 per 1000 person-years in the MMRV vaccine group compared to 42 per 1000 in the MMR and varicella vaccine group. This risk was about 2 times higher in children who received the combination shot (MMRV) versus the single shots (MMR and varicella).
The Study’s Conclusions Report:
CDC recommends providers who choose to use the combination MMRV vaccine be aware of and clearly communicate to parents and caregivers the increased risk of fever and seizure within the 7 to 10 days following vaccination.
Parents should be educated on the risk of seizure following the combination MMRV vaccine and know their options. Most children recover quickly from febrile seizures and have no lasting effects.
Top of PageRelated LinksMeasles-Mumps-Rubella-Varicella Combination Vaccine and the Risk of Febrile Seizures. Pediatrics 2010 Jul;126(1):e1-8.external iconVSD MMRV Safety StudyMeasles, Mumps, Rubella, and Varicella VaccineChildhood Vaccines and Febrile SeizuresFact Sheet for Providers on MMR and Varicella Vaccines or MMRV Vaccines
							
					
						Page last reviewed:  June 4, 2020					Content source: 	Centers for Disease Control and Prevention, National Center for Emerging and Zoonotic Infectious Diseases (NCEZID), Division of Healthcare Quality Promotion (DHQP) homeVaccine Safety
Safety Information by Vaccineplus icon
Chickenpox (Varicella) Vaccines
COVID-19 Vaccines
Diphtheria, Tetanus, and Pertussis Vaccines
Haemophilus influenzae type b (Hib) Vaccines
Hepatitis A Vaccines
Hepatitis B Vaccines
Human Papillomavirus (HPV) Vaccineplus icon
Questions about HPV Vaccine Safety
Influenza (Flu) Vaccines
Measles, Mumps, Rubella (MMR) Vaccinesplus icon
MMR Safety Studies
Measles, Mumps, Rubella, Varicella (MMRV) Vaccinesplus icon
VSD MMRV Safety Study
MMRV Safety Studies
MMRV and Febrile Seizures
Meningococcal Vaccines
Mpox Vaccines
Pneumococcal Vaccines
Polio Vaccine
Respiratory Syncytial Virus (RSV) Vaccine
Rotavirus Vaccine
Shingles (Herpes Zoster) Vaccines
Smallpox Vaccines
Questions and Concernsplus icon
Adjuvants
Autismplus icon
CDC Statement: 2004 Pediatrics Paper on MMR and Autism
Fainting after Vaccination
Febrile Seizures
Guillain-Barre Syndrome
Multiple Vaccinations at Once
Sudden Infant Death Syndrome (SIDS)
Thimerosalplus icon
CDC Study (2010 ) on Thimerosal and Risk of Autism
Thimerosal FAQs
Related Scientific Articles
Infant and Environmental Exposures to Thimerosal 2007 Study
Timeline: Thimerosal in Vaccines
Vaccines During Pregnancy FAQs
FAQs about Vaccine Recalls
Historical Vaccine Safety Concernsplus icon
GBS and Menactra Vaccine FAQs
Gardasil Vaccine Recall (2013) FAQs
Hep B and Multiple Sclerosis FAQs
Hib Vaccine Recall (2007) Summary
Narcolepsy Following Pandemrix Influenza Vaccination in Europe
Information for Healthcare Providersplus icon
Talking to Patients About Vaccine Safety
Reporting Adverse Events
Resources for Healthcare Providers
Information for Parents and Caregiversplus icon
Vaccine Safety FAQs
Researchplus icon
Publications
Partner Reports on Vaccine Safety
ISO Scientific Agenda
Ensuring Safetyplus icon
Overview, History, and How It Works
Side Effects and Adverse Events
Vaccine Safety Monitoringplus icon
Vaccine Adverse Event Reporting System (VAERS)
CISAplus icon
CISA Resources for Healthcare Professionals
Evaluation
Clinical Research Studies
Historical Background 2001-12
Publications
Technical Reports
Vaccine Safety Datalink (VSD)plus icon
Accessing Data from Vaccine Safety Datalink
Data Sharing Guidelines
Vaccine Safety Datalink Publications
V-safe
V-safe Publications
Emergency Preparedness
Vaccine Safety Partners
About ISO To receive email updates about this page, enter your email address: Email Address			What's this?				Submit


About CDC
					Contact Us
					800-232-4636
 Facebook Twitter Instagram LinkedIn Youtube Pinterest Snapchat
 CONTACT CDC
				Contact Us
							Call 800-232-4636
							Email Us
			ABOUT CDC
				About CDC
							Jobs
							Funding
			POLICIES
				Accessibility
							External Links
							Privacy
							Policies
							No Fear Act
							FOIA
							OIG
							Nondiscrimination
							Vulnerability Disclosure Policy
			CONNECT WITH US
				Facebook
								Twitter
								Instagram
								LinkedIn
							Youtube
								Pinterest
								Snapchat
								Email
			LANGUAGES
				Español
							繁體中文
							Tiếng Việt
							한국어
							Tagalog
							Русский
							العربية
							Kreyòl Ayisyen
							Français
							Polski
							Português
							Italiano
							Deutsch
							日本語
							فارسی
							English


U.S. Department of Health & Human Services
			Accessibility
			External Links
			Privacy
			Policies
			No Fear Act
			FOIA
			Nondiscrimination
			OIG
			Vulnerability Disclosure Policy
			USA.gov


Exit Notification / Disclaimer Policy Close
 Links with this icon  indicate that you are leaving the CDC website. The Centers for Disease Control and Prevention (CDC) cannot attest to the accuracy of a non-federal website.
				Linking to a non-federal website does not constitute an endorsement by CDC or any of its employees of the sponsors or the information and products presented on the website.
				You will be subject to the destination website's privacy policy when you follow the link.
				CDC is not responsible for Section 508 compliance (accessibility) on other federal or private website. Website Disclaimers
 Cancel Continue